Hematology/Blood Disorders Press Releases
Notable Labs to Present Analysis of Hematologic Oncology Drug Sensitivity Data
Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced that it is hosting a live webinar on February 9 to unveil their integrative data platform. The Notable data scientists will share…
Large International Study Pinpoints Impact of TP53 Mutations on Blood Cancer Severity
The MDS Foundation announces that a large international study led by researchers at Memorial Sloan Kettering finds that having two mutated copies of the TP53 gene, as opposed to a single mutated copy, is associated with worse outcomes in myelodysplastic syndrome and…
OrSense NBM-200 Non-Invasive Hemoglobin Device Implemented by Children's Hospital Los Angeles
OrSense Ltd., a leading developer of systems for non-invasive measurements of hemoglobin, announces the implementation of its NBM-200 non-invasive hemoglobin measurement device by Children’s Hospital Los Angeles (CHLA). CHLA is using OrSense NBM 200, a non-invasive medical device that measures…
OrSense NBM-200 Non-Invasive Hemoglobin Device Selected by the Central Blood Bank of Catalonia
OrSense Ltd., a leading developer of systems for non-invasive measurements of hemoglobin, today announces the selection of its NBM-200 non-invasive Hemoglobin measurement device by the Banc de Sang I Teixits, the central blood bank of Catalonia. Banc de Sang was…
FDA Grants Market Clearance for the OrSense NBM200; the First Noninvasive Hemoglobin System Cleared for Use in Blood Donation Centers
OrSense Ltd., a leading developer of systems for non-invasive measurements of Hemoglobin, today announces that its NBM200 non-invasive Hemoglobin measurement device has received FDA/CBER 510(K) clearance for use in blood banks. The OrSense NBM200 device provides painless, reliable and efficient…
Addressing Platelet Refractoriness: Giving Hematology-Oncology Patients the Best Chance of Success, New Webinar Hosted by Xtalks
Join the live session on Wednesday, Jan. 24, 2018 with featured speaker Dr. Elisabeth Maurer-Spurej, Founder of LightIntegra Technology and principal inventor of ThromboLUX®. Dr. Maurer-Spurej will introduce activated platelets and their prevalence, discuss the impacts of activated platelet transfusions,…
Leukemia and Lymphoma Society and Subaru 2016 Share the Love® Event Raises More Than $24 Million in Charitable Donations
Subaru of America, Inc. today announced it has donated more than $23.4 million to national and local charities during its annual Share the Love event in 2016, bringing the total donated throughout the life of the program to more than $94 million. Held…
Blood Thinner Eliquis Associated With Uncontrollable Bleeding in Users Consumer Safety Watch Warns
Alan Christopher, a consumer safety advocate from Consumer Safety Watch is warning that Pfizer and Bristol-Myers Squibb’s blood thinner Eliquis (apixaban) has been associated with uncontrollable bleeding in users and does not have an antidote, which significantly increases the chances of…
Patient Readiness Institute (PRI) Works With the American Red Cross to Implement MyBloodHealth® System to Provide "Patient Specific Blood Management" for Patients Having Surgery
Since 2012, the Patient Readiness Institute (PRI) has provided a simple, reliable, outsourced peri-operative “blood health” optimization solution for surgical patients that minimizes the likelihood of anemia before surgery, transfusion and other potentially adverse events. The American Red Cross is…